Cman,
The potential reward is huge if OSL can pull it off. I think that OSL is very smart targeting the market for pancreatic cancer. There is a large unmet clinical demand. The technology itself is simple to understand. I like the concept of technology and I think it can work. And there could be applications in other tumors like liver cancer.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.015(1.30%) |
Mkt cap ! $21.46M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.16 | $1.14 | $25.56K | 22.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 14709 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 14688 | 2 |
View Market Depth
| Last trade - 11.40am 28/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |